{
    "title": "U.S. FDA extends review of BioMarin's bleeding disorder therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11830557/U-S-FDA-extends-review-BioMarins-bleeding-disorder-therapy.html",
    "date": "2023-03-07",
    "keywords": [
        "drug",
        "fda",
        "gene",
        "therapy",
        "bleeding",
        "companys",
        "year",
        "decision",
        "march",
        "food",
        "administration",
        "review",
        "incs",
        "delay",
        "approval",
        "country",
        "monday",
        "time",
        "analysis",
        "latestage",
        "study",
        "biomarin",
        "june",
        "regulator",
        "date",
        "onetime",
        "treatment",
        "hemophilia",
        "disorder",
        "blood",
        "protein",
        "factor",
        "need",
        "marketing",
        "authorization",
        "union",
        "august",
        "reporting",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "vinay",
        "dwivedi"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}